Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopaedics, Rigshospitalet, Glostrup, Denmark.
Department of Rheumatology, Skaraborg Hospital, Skövde, Sweden.
Int J Rheum Dis. 2020 Apr;23(4):488-498. doi: 10.1111/1756-185X.13790. Epub 2020 Jan 28.
To investigate whether magnetic resonance imaging (MRI) pathologies in the wrist/hand of rheumatoid arthritis (RA) patients are associated with patient-reported outcomes (PROs) at clinical remission and relapse.
Wrist/hand MRIs and wrists/hands/feet radiographs were obtained in 114 established RA patients in clinical remission, before tapering their biologic disease-modifying antirheumatic drugs. MRIs were assessed according to the Outcome Measures in Rheumatology (OMERACT) RA MRI score (RAMRIS) for inflammation (synovitis/tenosynovitis/bone marrow edema) and damage (bone erosion/joint space narrowing) at baseline (ie remission) and in case of a relapse (n = 70). Radiographs were assessed according to the Sharp/van der Heijde (SvH) method at baseline. These scores were assessed for associations with health assessment questionnaires (HAQ), visual analog scales (VAS global/pain), EuroQol-5 dimensions and Short-Form 36 physical and mental component summary (SF-36 PCS/MCS) using Spearman correlations, univariate/multivariable linear regression analyses and generalized estimating equations. Furthermore, MRI pathologies were assessed for association with specific hand-related HAQ items using Jonckheere trend tests.
Magnetic resonance imaging-assessed damage was associated with impaired HAQ and SF-36 PCS at remission and relapse (P < .01), independent of clinical and radiographic measures, and was also associated with most of the hand-related HAQ items (P < .03). In multivariate models including MRI, SvH scores were not associated with PROs. MRI-assessed inflammation was not associated with PROs at remission or relapse.
Magnetic resonance imaging-assessed wrist/hand damage, but not inflammation, in patients with established RA is associated with patient-reported physical impairment at remission and relapse. The amount of damage in the wrist/hand is associated with reduced hand function.
探讨类风湿关节炎(RA)患者腕/手部磁共振成像(MRI)病变是否与临床缓解和复发时的患者报告结局(PRO)相关。
在开始减少生物疾病修正抗风湿药物之前,对 114 例处于临床缓解期的确诊 RA 患者进行腕/手部 MRI 和腕/手/脚 X 线摄影检查。MRI 按照风湿病疗效评估(OMERACT)RA MRI 评分(RAMRIS)标准,评估基线(即缓解期)和复发时(n=70)的炎症(滑膜炎/腱鞘炎/骨髓水肿)和损伤(骨侵蚀/关节间隙变窄)。X 射线摄影按照Sharp/van der Heijde(SvH)方法在基线时进行评估。使用 Spearman 相关分析、单变量/多变量线性回归分析和广义估计方程,评估这些评分与健康评估问卷(HAQ)、视觉模拟量表(VAS 整体/疼痛)、EuroQol-5 维度和 36 项简短健康调查量表身心成分综合评分(SF-36 PCS/MCS)之间的相关性。此外,还使用 Jonckheere 趋势检验评估 MRI 病变与特定手部相关 HAQ 项目之间的关联。
缓解和复发时,MRI 评估的损伤与 HAQ 和 SF-36 PCS 受损相关(P<0.01),独立于临床和放射学测量,并且还与大多数手部相关的 HAQ 项目相关(P<0.03)。在包含 MRI 的多变量模型中,SvH 评分与 PRO 无关。缓解或复发时,MRI 评估的炎症与 PRO 无关。
在确诊的 RA 患者中,腕/手部 MRI 评估的损伤,但不是炎症,与缓解和复发时的患者报告的身体功能障碍相关。腕/手部的损伤程度与手部功能降低有关。